AboutKelly Blair

As a leader on Sg2’s Consulting team, Kelly leverages 20 years of health care experience and an entrepreneurial spirit to help her clients develop strategies grounded in the present while also anticipating the future. Her expertise includes alternative reimbursement models, service line strategy and payer strategy.

During her career, Kelly has worked with a variety of health care companies, ranging from a Fortune 15 insurance company powerhouse to a health care start-up company. She has focused primarily on improving the quality and affordability of health care by advancing an agenda of collaboration and innovation. Her product development experience includes risk-based solutions in the specialty areas of infertility, oncology, orthopedics and advanced heart failure.

Most recently Kelly was chief operating officer at an oncology management start-up company promoting value-based network solutions to payers and providers. She led MedSolutions’ oncology portfolio expansion as the vice president of oncology after serving as Optum’s general manager for the women’s health and oncology service lines for 5 years. She also spent 10 years with UnitedHealthcare developing and executing product road maps for provider specialty networks, including specialty pharmacy and laboratory.

Kelly earned a master of public administration from the College of Charleston in South Carolina, concentrating on public health policy and alternative provider reimbursement models. She also earned a master certificate in project management from the George Washington University School of Business and, in 2013, completed a start-up accelerator program through the Nashville Entrepreneur Center in Tennessee. She holds a bachelor of arts in political science and economics from Northwest Missouri State University.

Kelly is an active mentor in Menttium International, a corporate mentoring program for emerging business leaders.

"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Facebook Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube